Skip to main content
Top

Cancer & Metabolism

2013 - 2024
Volumes
14
Issues
Chevron right icon
Issue 1/2024
Latest issue

About this journal

Cancer & Metabolism is proud to have leading experts who drive research in this niche field on its Editorial Board, reviewing manuscripts for quality, rather than focusing simply on novelty. Our editors fully support well-thought out research methods and experimental designs that produce negative results, as well as reaffirm established literature. We welcome submissions on all aspects of the relationship between cancer and metabolism, including but not limited to, cell and tumor metabolism pathways, metabolite targeting, and metabolomic applications.

Metadata
Title
Cancer & Metabolism
Coverage
Volume 1/2013 - Volume 12/2024
Publisher
BioMed Central
Electronic ISSN
2049-3002
Journal ID
40170
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine